DAVID P. SCHENKEIN, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

REGENERON PHARMACEUTICALS, INC.

Filing Date Source Excerpt
2024-04-25 David P. Schenkein, M.D. - Director since 2023, Age 66. Board and Committee Membership—2023 Attendance: Technology Committee. Compensation: $1,031,155.

Data sourced from SEC filings. Last updated: 2025-12-06